AS

Amandeep Singh Anand

Active Director Director DIN 09453668
DIN 09453668 First appointment Dec 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Amandeep Singh Anand

Data last updated:

Amandeep Singh Anand is a Director at Burgeon Health Series Private Limited (since 2021). The company operates in Pharma. Burgeon Health Series Private Limited reported revenue of ₹3.82 Cr (FY 2025).

DIN 09453668
Primary Designation Director
Industry Pharma
First Appointment 31 Dec 2021
Oldest Company Age 4 yrs
Largest company Burgeon Health Series Private Limited · ₹3.82 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Dec 20212021₹3.82 Cr (FY 2025)Active

Board colleagues of Amandeep Singh Anand

Directorship timeline

Open interactive timeline →
Burgeon Health Series Private Limited
Premium access

Shareholding and investment profile for Amandeep Singh Anand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amandeep Singh Anand

Amandeep Singh Anand currently holds 1 directorship: Burgeon Health Series Private Limited (Director, since 31 Dec 2021, revenue ₹3.82 Cr (FY 2025)).

Amandeep Singh Anand was first appointed on 31 Dec 2021 as Director at Burgeon Health Series Private Limited.

The current boards of Amandeep Singh Anand's companies include Harsimran Singh Kalra (Burgeon Health Series Private Limited), Jitender Mohan Kalra (Burgeon Health Series Private Limited), Ravneet Singh (Burgeon Health Series Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available